SUMMARY
DelveInsight’s,“ Pyelonephritis-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Pyelonephritis. This report provides information on the therapeutic development based on the Pyelonephritis dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
• The report provides a snapshot of the global therapeutic landscape of Pyelonephritis
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Pyelonephritis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Pyelonephritis and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

※関連の医療情報レポート

腎盂腎炎(Pyelonephritis)：治療薬開発パイプライン動向2016DIPR2016556 / DelveInsight / 2016年版 / ※本調査レポートでは、世界における腎盂腎炎(Pyelonephritis)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の薬剤リスト等をお届けしています。また、腎盂腎炎(Pyelonephritis)治療薬開発に取り組んでいる企業情報も提供しています。 ・腎盂腎炎(Pyelonephritis)の概要 ・腎盂腎炎(Pyelonephritis)の治療薬パイプライン概要 ・企業別開発中の腎盂腎炎(Pyelonephritis)治療薬 ・後期治験段階の薬剤(Filed & Phase III)：比較分析 ・中期治験段階の薬剤(Phase II)：比較分析...SUMMARY DelveInsight’s, “ Pyelonephritis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Pyelonephritis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Pyelonephritis. DelveInsight’s Report also assesses the Pyelonephritis therapeutics by Monotherapy, Combination...

腎盂腎炎(Pyelonephritis)：治療薬開発パイプライン動向2014DELVE41017595 / DelveInsight / 2014年版 / 本調査レポートでは、世界における腎盂腎炎(Pyelonephritis)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の製品リスト等をお届けしています。また、腎盂腎炎(Pyelonephritis)治療薬開発に取り組んでいる企業情報も提供しています。（※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。） ・腎盂腎炎(Pyelonephritis)の概要 ・腎盂腎炎(Pyelonephritis)のパイプライン製品概要 ・企業別開発中の治療薬 ・後期治験段階の製品(Filed & Phase III)：比較分析 ・中期治験段階の製品(Phase II)：比較分析...SUMMARY DelveInsight’s,“ Pyelonephritis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Pyelonephritis. This report provides information on the therapeutic development based on the Pyelonephritis dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products....

腎盂腎炎(Pyelonephritis)：世界の治験レビュー2014（地域別/フェーズ別治験件数、主要企業/研究機関動向）GDCLT1133 / GlobalData / 2014年版 / 当調査レポートでは、世界における腎盂腎炎(Pyelonephritis) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。 ・イントロダクション - 腎盂腎炎(Pyelonephritis) - 当レポートの概要 ・腎盂腎炎(Pyelonephritis)：各地域別治験状況 - 各国の治験件数及び平均被験者数...[Summary] GlobalData's clinical trial report, [Pyelonephritis - Global Clinical Trials Review 2014] provides data on the Pyelonephritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pyelonephritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pyelonephritis. This report is built using data and information...

腎盂腎炎(Pyelonephritis)：治療薬市場動向2015（市場規模、APIメーカー動向、上市品、フェーズ3治験）DIIR2015133 / DelveInsight / 2015年版 / ...DelveInsight’s, “Pyelonephritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Pyelonephritis. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Pyelonephritis. The Report gives insights into patents providing thepatent protection data and marketing exclusivity of all the drugs across the Pyelonephritis. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturersacross the...

腎盂腎炎(Pyelonephritis)：世界の治験レビュー2014年下半期版GDHC2466CTIDB / GlobalData / 2014年12月15日 / 当調査レポートでは、世界における腎盂腎炎(Pyelonephritis) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。 ・イントロダクション - 腎盂腎炎(Pyelonephritis) - 当レポートの概要 ・腎盂腎炎(Pyelonephritis)：各地域別治験状況 - 各国の治験件数及び平均被験者数...Pyelonephritis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pyelonephritis Global Clinical Trials Review, H2, 2014" provides data on the Pyelonephritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pyelonephritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pyelonephritis. This...

腎盂腎炎(Pyelonephritis)：世界の治験レビュー2014年下半期版GDHC2466CTIDB / GlobalData / 2014年12月15日 / 当調査レポートでは、世界における腎盂腎炎(Pyelonephritis) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。 ・イントロダクション - 腎盂腎炎(Pyelonephritis) - 当レポートの概要 ・腎盂腎炎(Pyelonephritis)：各地域別治験状況 - 各国の治験件数及び平均被験者数...Pyelonephritis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pyelonephritis Global Clinical Trials Review, H2, 2014" provides data on the Pyelonephritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pyelonephritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pyelonephritis. This...